These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 10876800

  • 1. [Candesartan cilexetil: pharmacological properties and protective effects against organ damage of a novel nonpeptide angiotensin II-receptor antagonist].
    Inada Y, Naka T.
    Nihon Yakurigaku Zasshi; 2000 Mar; 115(3):151-60. PubMed ID: 10876800
    [Abstract] [Full Text] [Related]

  • 2. Pharmacologic properties of candesartan cilexetil--possible mechanisms of long-acting antihypertensive action.
    Inada Y, Ojima M, Kanagawa R, Misumi Y, Nishikawa K, Naka T.
    J Hum Hypertens; 1999 Jan; 13 Suppl 1():S75-80. PubMed ID: 10076925
    [Abstract] [Full Text] [Related]

  • 3. Differences among angiotensin II type 1 receptor blockers: characteristics of candesartan cilexetil.
    Unger T.
    Blood Press Suppl; 2000 Jan; 1():14-8. PubMed ID: 11059630
    [Abstract] [Full Text] [Related]

  • 4. Significance of angiotensin type 1 receptor blockade: why are angiotensin II receptor blockers different?
    Unger T.
    Am J Cardiol; 1999 Nov 18; 84(10A):9S-15S. PubMed ID: 10588089
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacological profiles of candesartan cilexetil (TCV-116)].
    Inada Y.
    Nihon Rinsho; 1999 May 18; 57(5):1130-6. PubMed ID: 10361446
    [Abstract] [Full Text] [Related]

  • 6. Candesartan cilexetil: a review of its preclinical pharmacology.
    Nishikawa K, Naka T, Chatani F, Yoshimura Y.
    J Hum Hypertens; 1997 Sep 18; 11 Suppl 2():S9-17. PubMed ID: 9330999
    [Abstract] [Full Text] [Related]

  • 7. [Angiotensin II receptor antagonists: candesartan cilexetil].
    Naka T, Kubo K, Nishikawa K, Inada Y, Furukawa Y.
    Yakugaku Zasshi; 2000 Dec 18; 120(12):1261-75. PubMed ID: 11193378
    [Abstract] [Full Text] [Related]

  • 8. A new class of diacidic nonpeptide angiotensin II receptor antagonists: candesartan cilexetil.
    Naka T, Kubo K.
    Curr Pharm Des; 1999 Jun 18; 5(6):453-72. PubMed ID: 10390609
    [Abstract] [Full Text] [Related]

  • 9. A new class of diacidic nonpeptide angiotensin II receptor antagonists: candesartan cilexetil.
    Naka T, Kubo K, Inada Y, Nishikawa K.
    Drug Des Discov; 1999 Aug 18; 16(2):95-108. PubMed ID: 10533806
    [Abstract] [Full Text] [Related]

  • 10. Candesartan cilexetil: an angiotensin II receptor blocker.
    Stoukides CA, McVoy HJ, Kaul AF.
    Ann Pharmacother; 1999 Dec 18; 33(12):1287-98. PubMed ID: 10630830
    [Abstract] [Full Text] [Related]

  • 11. In vivo inhibition of angiotensin receptors in the rat kidney by candesartan cilexetil: a comparison with losartan.
    Fabiani ME, Dinh DT, Nassis L, Casley DJ, Johnston CI.
    Am J Hypertens; 2000 Sep 18; 13(9):1005-13. PubMed ID: 10981551
    [Abstract] [Full Text] [Related]

  • 12. Newly emerging pharmacologic differences in angiotensin II receptor blockers.
    Oparil S.
    Am J Hypertens; 2000 Jan 18; 13(1 Pt 2):18S-24S. PubMed ID: 10678284
    [Abstract] [Full Text] [Related]

  • 13. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
    Paull JR, Widdop RE.
    J Hypertens; 2001 Aug 18; 19(8):1393-402. PubMed ID: 11518847
    [Abstract] [Full Text] [Related]

  • 14. Combined blockade of AT1-receptors and ACE synergistically potentiates antihypertensive effects in SHR.
    Raasch W, Jöhren O, Schwartz S, Gieselberg A, Dominiak P.
    J Hypertens; 2004 Mar 18; 22(3):611-8. PubMed ID: 15076168
    [Abstract] [Full Text] [Related]

  • 15. Candesartan cilexetil: a new, long-acting, effective angiotensin II type 1 receptor blocker.
    Sever P.
    J Hum Hypertens; 1997 Sep 18; 11 Suppl 2():S91-5. PubMed ID: 9331018
    [Abstract] [Full Text] [Related]

  • 16. Candesartan cilexetil: development and preclinical studies.
    Gohlke P, Jürgensen T, von Kügelgen S, Unger T.
    Drugs Today (Barc); 1999 Feb 18; 35(2):105-15. PubMed ID: 12973413
    [Abstract] [Full Text] [Related]

  • 17. Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
    Fridman K, Andersson OK, Wysocki M, Friberg P, Sunzel M.
    Eur J Clin Pharmacol; 1998 Sep 18; 54(7):497-501. PubMed ID: 9832289
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
    Kim S, Iwao H.
    J Hypertens Suppl; 1997 Dec 18; 15(6):S3-7. PubMed ID: 9493120
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.